CT HB 5044 Vaccine Bill Sparks Heated Capitol Debate

Connecticut already leads the nation in childhood vaccination rates, but Ned Lamont wants to make sure the state can hold that position even as federal health guidance shifts under Washington’s watch.

A public hearing Wednesday at the State Capitol drew more than 500 registered speakers on two proposals that would expand Connecticut’s authority over immunizations. Hours into the session, the testimony ran heavily against the measures, with opponents framing the bills as government overreach and an infringement on religious liberty.

At the center of the debate is H.B. 5044, a bill that originated from the governor’s office. A companion proposal would similarly empower Connecticut’s Public Health Commissioner to set vaccine recommendations, require insurers to cover those recommended shots, and allow the state to purchase doses from sources beyond the Centers for Disease Control and Prevention. Currently, state law ties Connecticut to the CDC as its sole purchasing source, a constraint the legislation would dissolve.

Lamont has made clear he sees the moment as one requiring a direct statement of intent. “We are going with the traditional vaccination schedule. It’s been endorsed by all those medical groups. No politics. Let’s follow the lead of medical science,” he said in an interview this week. The governor framed the push as a response to “mixed messages” from a federal Department of Health and Human Services now operating under Robert F. Kennedy Jr., a longtime vaccine skeptic who now leads the agency.

The federal picture has changed substantially since the start of the year. The CDC issued a new tiered recommendation schedule for childhood vaccines, sorting them into three categories: shots recommended for all children, those for specific high-risk groups, and those where the choice gets left to “shared clinical decision-making” between patients and physicians. That restructuring reduced the number of vaccines broadly recommended for all children from 17 to 11. Flu, hepatitis A, and hepatitis B were among the vaccines that lost their universal recommendation status.

The ripple effects have been significant. As of January, 28 states, Connecticut among them, had announced they would not follow the updated CDC schedule for at least some childhood vaccines, instead leaning on prior federal guidance, their own state recommendations, or the standards of external medical bodies. That resistance has pushed state legislatures to formalize their independence from CDC guidance, and the Connecticut proposals before lawmakers Wednesday represent that same impulse.

The existing authority of Connecticut’s Department of Public Health commissioner covers vaccine recommendations for children, establishing what amounts to a standard of care. The pending bills would extend that authority to adults as well, a significant expansion. The insurance coverage provisions would guarantee that any shots falling under the commissioner’s recommendations are covered, which backers argue removes cost as a barrier to compliance.

Connecticut’s standing on childhood vaccination is not a minor credential. The state posted the highest measles, mumps, and rubella vaccination rates in the country among kindergarteners during the 2024-25 school year. Supporters of the legislation argue that protecting that record requires institutional independence from a CDC whose recommendations now carry more political uncertainty than at any previous point in memory.

Opponents who testified Wednesday did not dispute the vaccination data. Their concerns centered on the scope of authority the bills would hand state officials, particularly the extension of power over adult immunization schedules. For many speakers, the proposals moved Connecticut in the wrong direction, concentrating decision-making in the hands of an appointed official rather than leaving it between individuals and their doctors.

The proposals face a legislature that has historically been receptive to public health initiatives, but the volume of opposition testimony suggests the path will not be straightforward. The question for Connecticut lawmakers is whether the state’s strong vaccination record can survive a prolonged period of federal uncertainty, or whether the legal architecture needs reinforcing now, before that record begins to slip.